NCT04781777

Brief Summary

Insulin as an adjuvant to local anesthetic and cortisone to decrease pain recurrence

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2021

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

2 months

First QC Date

February 23, 2021

Last Update Submit

March 1, 2021

Conditions

Pain Relief

Outcome Measures

Primary Outcomes (1)

  • pain neuropathy

    relief chronic pain from caroal tunnel

    12 weeks

Study Arms (2)

Control group

NO INTERVENTION

Dexmehtasone and local anesthetics in carpal tunnel syndrome

Insulin group

ACTIVE COMPARATOR

insulin added to dexamehtasone and local anesthetics

Drug: insulin

Interventions

insulinDRUG

sonar guided insulin combined with dexamethasone and local anesthetics

Also known as: Sonar guided median nerve hydrodissection
Insulin group

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Diabetic patients with mild to moderate carpal tunnel syndrome

You may not qualify if:

  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Insulin

Intervention Hierarchy (Ancestors)

ProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and ICU

Study Record Dates

First Submitted

February 23, 2021

First Posted

March 4, 2021

Study Start

March 1, 2021

Primary Completion

May 5, 2021

Study Completion

June 1, 2021

Last Updated

March 4, 2021

Record last verified: 2021-03